Literature DB >> 12384856

An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.

Laura Chow1, Neil E Brown, Dennis Kunimoto.   

Abstract

The development of pulmonary aspergilloma and invasive aspergillosis is a rare complication of cystic fibrosis. We describe a 29-year-old patient with cystic fibrosis who had invasive pulmonary aspergillosis that was not cured by amphotericin B, liposomal amphotericin B, or itraconazole. This patient was subsequently successfully treated and cured with the novel antifungal agent voriconazole.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384856     DOI: 10.1086/343743

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

Review 1.  Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

Authors:  Helen W Boucher; Andreas H Groll; Christine C Chiou; Thomas J Walsh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.

Authors:  Ricardo Alberto Mosquera; Lila Estrada; Roya Mohebpour Clements; Cindy K Jon
Journal:  BMJ Case Rep       Date:  2013-11-18

3.  Aspergillus fumigatus invasion increases with progressive airway ischemia.

Authors:  Joe L Hsu; Mohammad A Khan; Raymond A Sobel; Xinguo Jiang; Karl V Clemons; Tom T Nguyen; David A Stevens; Marife Martinez; Mark R Nicolls
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

4.  Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.

Authors:  Linna Huang; Hangyong He; Jingjing Jin; Qingyuan Zhan
Journal:  BMC Infect Dis       Date:  2017-03-14       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.